Susquehanna International Group’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.97M | Sell |
152,852
-165,486
| -52% | -$5.38M | ﹤0.01% | 1306 |
|
|
2025
Q1 | $12M | Buy |
318,338
+192,942
| +154% | +$7.29M | ﹤0.01% | 548 |
|
|
2024
Q4 | $10.3M | Buy |
125,396
+80,926
| +182% | +$6.62M | ﹤0.01% | 703 |
|
|
2024
Q3 | $5.08M | Buy |
44,470
+20,343
| +84% | +$2.32M | ﹤0.01% | 1037 |
|
|
2024
Q2 | $1.82M | Sell |
24,127
-19,684
| -45% | -$1.49M | ﹤0.01% | 1853 |
|
|
2024
Q1 | $2.99M | Buy |
43,811
+13,113
| +43% | +$896K | ﹤0.01% | 1414 |
|
|
2023
Q4 | $1.93M | Buy |
30,698
+8,993
| +41% | +$565K | ﹤0.01% | 1988 |
|
|
2023
Q3 | $1.11M | Sell |
21,705
-5,684
| -21% | -$290K | ﹤0.01% | 2446 |
|
|
2023
Q2 | $1.37M | Sell |
27,389
-63,216
| -70% | -$3.16M | ﹤0.01% | 2329 |
|
|
2023
Q1 | $3.4M | Buy |
90,605
+74,647
| +468% | +$2.8M | ﹤0.01% | 1392 |
|
|
2022
Q4 | $765K | Sell |
15,958
-27,498
| -63% | -$1.32M | ﹤0.01% | 2627 |
|
|
2022
Q3 | $1.04M | Sell |
43,456
-19,375
| -31% | -$465K | ﹤0.01% | 2484 |
|
|
2022
Q2 | $1.37M | Buy |
62,831
+47,071
| +299% | +$1.02M | ﹤0.01% | 2104 |
|
|
2022
Q1 | $381K | Sell |
15,760
-4,384
| -22% | -$106K | ﹤0.01% | 4057 |
|
|
2021
Q4 | $479K | Buy |
20,144
+5,378
| +36% | +$128K | ﹤0.01% | 3866 |
|
|
2021
Q3 | $375K | Sell |
14,766
-4,170
| -22% | -$106K | ﹤0.01% | 4044 |
|
|
2021
Q2 | $426K | Buy |
+18,936
| New | +$426K | ﹤0.01% | 4075 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5602 |
|